<DOC>
	<DOCNO>NCT01900418</DOCNO>
	<brief_summary>For post-menopausal woman diagnose hormone-receptor positive breast cancer tumor , aromatase inhibitor ( AIs ) standard adjuvant hormone treatment prolong disease-free survival time-to-recurrence . Unfortunately , joint pain/stiffness/achiness ( arthralgia ) common side-effect AIs . This `` proof-of-concept '' study explore evidence-based physical activity ( PA ) program- Arthritis Foundation 's Walk Ease ( WWE ) program- adapt breast cancer survivor AI therapy : 1 ) Help maintain achieve recommend level PA , 2 ) reduce joint pain/stiffness/achiness , 3 ) thereby enable remain AI therapy prescribed .</brief_summary>
	<brief_title>Physical Activity Reduce Joint Pain During Aromatase Inhibitor Therapy</brief_title>
	<detailed_description />
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Taking aromatase inhibitor adjuvant treatment State I , II , II breast cancer least 4 week Experiencing mild joint pain/symptoms 21 old permission physician engage moderate intensity physical activity Undergoing chemotherapy and/or radiation therapy time study period Scheduled major surgery study period Presently engage high level physical activity daily basis Less 21 year age Unable walk engage moderate intensity physical activity</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>physical activity</keyword>
	<keyword>joint pain</keyword>
</DOC>